EpiEndo Pharmaceuticals
EpiEndo Pharmaceuticals is a pharmaceutical company focused on novel solutions for chronic airway diseases.
Total raised
€25M
€25,300,000
Funding rounds
3
Investors
4
distinct backers
Active since
2018-12
latest 2021-08
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood18
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ 12y since founding
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-08-18 | Series A | €20M | Iðunn Venture Fund,ABC Ventures,European Innovation Council (EIC),Flerie Invest | View deal → |
| 2019-10-01 | Grant | €4.5M | — | View deal → |
| 2019-01-01 | Other | €800k | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech
- Doctolib€734MFrance · E-commerce